NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



AIDS/HIV Therapy



Systematic HAART for HIV patients with >500 T cell counts not supported by data



September 9th, 2004

The data does not support systematic highly active antiretroviral therapy for HIV patients with >500 T cell counts.

"To assess the clinical, immunological and virological evolution in HIV-1 infected patients with CD4 T-cell count above 500/mm3, a historical cohort of 202 untreated and 96 patients treated with HAART was longitudinally studied (median follow up 36 months)," wrote investigators in France.

"Fourteen untreated and 2 treated patients experienced clinical progression (p=.09). The difference between baseline CD4 T-cell count and after 3 years was -240/mm3 in the untreated group vs. +19/mm3 in the HAART...


Source: Blood Weekly (2004-09-09)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login